Cargando…

Metabolic biomarkers in lung cancer screening and early diagnosis (Review)

Late diagnosis is one of the major contributing factors to the high mortality rate of lung cancer, which is now the leading cause of cancer-associated mortality worldwide. At present, low-dose CT (LDCT) screening in the high-risk population, in which lung cancer incidence is higher than that of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yongjie, Dong, Xuesi, Qin, Chao, Wang, Fei, Cao, Wei, Li, Jiang, Yu, Yiwen, Zhao, Liang, Tan, Fengwei, Chen, Wanqing, Li, Ni, He, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193366/ https://www.ncbi.nlm.nih.gov/pubmed/37216157 http://dx.doi.org/10.3892/ol.2023.13851

Ejemplares similares

Sex disparity of lung cancer risk in non-smokers: a multicenter population-based prospective study based on China National Lung Cancer Screening Program
por: Wu, Zheng, et al.
Publicado: (2022)

Use of Breast Cancer Risk Factors to Identify Risk-Adapted Starting Age of Screening in China
por: Zheng, Yadi, et al.
Publicado: (2022)

Lung cancer risk prediction models based on pulmonary nodules: A systematic review
por: Wu, Zheng, et al.
Publicado: (2022)

Uptake of lung cancer screening with low-dose computed tomography in China: A multi-centre population-based study
por: Cao, Wei, et al.
Publicado: (2022)

A strategy to reduce the false‐positive rate after low‐dose computed tomography in lung cancer screening: A multicenter prospective cohort study
por: Wu, Zheng, et al.
Publicado: (2023)

Association Between Socioeconomic Status and Adherence to Fecal Occult Blood Tests in Colorectal Cancer Screening Programs: Systematic Review and Meta-Analysis of Observational Studies
por: Luo, Zilin, et al.
Publicado: (2023)

Menstrual factors, reproductive history, and risk of lung cancer: a multi-center population-based cohort study in Chinese females
por: Yang, Zhuoyu, et al.
Publicado: (2021)

Plasma metabolomics study in screening and differential diagnosis of multiple primary lung cancer
por: Liu, Zixu, et al.
Publicado: (2023)

BMI changes and the risk of lung cancer in male never‐smokers: A prospective cohort study
por: Wu, Zheng, et al.
Publicado: (2022)

Associations between female lung cancer risk and sex steroid hormones: a systematic review and meta-analysis of the worldwide epidemiological evidence on endogenous and exogenous sex steroid hormones
por: Zeng, Hui, et al.
Publicado: (2021)

Screening and identification of biomarkers associated with the diagnosis and prognosis of lung adenocarcinoma
por: Wang, Yanyun, et al.
Publicado: (2020)

Biomarkers for Gastric Cancer Screening and Early Diagnosis
por: Herrera-Pariente, Cristina, et al.
Publicado: (2021)

Assessment of Barriers and Challenges to Screening, Diagnosis, and Biomarker Testing in Early-Stage Lung Cancer
por: Zarinshenas, Reza, et al.
Publicado: (2023)

Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
por: Tang, Yong, et al.
Publicado: (2017)

Geographic disparities in trends of thyroid cancer incidence and mortality from 1990 to 2019 and a projection to 2030 across income-classified countries and territories
por: Wang, Chenran, et al.
Publicado: (2023)

Parkinson’s Disease Gene Biomarkers Screened by the LASSO and SVM Algorithms
por: Bao, Yiwen, et al.
Publicado: (2023)

Identification of Metabolism-Associated Biomarkers for Early and Precise Diagnosis of Oral Squamous Cell Carcinoma
por: Wang, Yuhan, et al.
Publicado: (2022)

Urinary Biomarkers for Early Diagnosis of Lung Cancer
por: Gasparri, Roberto, et al.
Publicado: (2021)

Screening and identification of potential protein biomarkers for the early diagnosis of acute myocardial infarction
por: Shi, Li-Ying, et al.
Publicado: (2021)

Circulating miRNAs in Serum as Biomarkers for Early Diagnosis of Non-small Cell Lung Cancer
por: Duan, Xiaotong, et al.
Publicado: (2021)

Glycoproteomics revealed novel N-glycosylation biomarkers for early diagnosis of lung adenocarcinoma cancers
por: Fang, Kai, et al.
Publicado: (2022)

Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers
por: Sun, Sijin, et al.
Publicado: (2021)

Blind spot in lung cancer lymph node metastasis: Cross‐lobe peripheral lymph node metastasis in early stage patients
por: Li, Ning, et al.
Publicado: (2018)

Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosis
por: Liu, Xiao-Na, et al.
Publicado: (2019)

Biomarkers in Early Diagnosis and Early Stage Lung Cancer: The Clinician’s Point of View
por: Gasparri, Roberto, et al.
Publicado: (2020)

The Serum Metabolic Biomarkers in Early Diagnosis and Risk Stratification of Acute Coronary Syndrome
por: Jiang, Huali, et al.
Publicado: (2020)

Cancer statistics in China and United States, 2022: profiles, trends, and determinants
por: Xia, Changfa, et al.
Publicado: (2022)

Circulating Heat Shock Protein 70 Is a Novel Biomarker for Early Diagnosis of Lung Cancer
por: Tang, Tielong, et al.
Publicado: (2018)

CTAPIII/CXCL7: a novel biomarker for early diagnosis of lung cancer
por: Du, Qiang, et al.
Publicado: (2018)

SIRT3 acts as a novel biomarker for the diagnosis of lung cancer: A retrospective study
por: Tao, Feng, et al.
Publicado: (2021)

Screening of sensitive in vivo characteristics for early keratoconus diagnosis: a multicenter study
por: Chen, Xuan, et al.
Publicado: (2023)

Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis
por: Zhu, Mingchuang, et al.
Publicado: (2022)

Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma
por: Chen, Hongda, et al.
Publicado: (2018)

Trans-omics biomarker model improves prognostic prediction accuracy for early-stage lung adenocarcinoma
por: Dong, Xuesi, et al.
Publicado: (2019)

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis
por: Zhu, Mingchuang, et al.
Publicado: (2022)

Peripheral Blood Biomarkers for Early Diagnosis, Severity, and Prognosis of Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung Cancer
por: Lin, Xinqing, et al.
Publicado: (2021)

Improved esophageal squamous cell carcinoma screening effectiveness by risk‐stratified endoscopic screening: evidence from high‐risk areas in China
por: Li, He, et al.
Publicado: (2021)

Risk prediction model for lung cancer incorporating metabolic markers: Development and internal validation in a Chinese population
por: Lyu, Zhangyan, et al.
Publicado: (2020)

Trends and risk factors of lung cancer in China
por: He, Siyi, et al.
Publicado: (2020)

Identification and validation of novel DNA methylation markers for early diagnosis of lung adenocarcinoma
por: Li, Miao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_feaapk504v01e98bp4umsjg4kn